EUVIMEDEUVIMED entdecken
Crossref

Rising incidence of Pneumocystis pneumonia: A population-level descriptive ecological study in England

Katharine Pates, Jimstan Periselneris, Mark D Russell, Varun Mehra, Silke Schelenz, James B Galloway

Journal of Infection · 2023

DOI: 10.1016/j.jinf.2023.02.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Infection, 2023. Verfasst von Katharine Pates und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Kings College Hospital, Kings College Hospital NHS Foundation Trust, London, UK. Electronic address: k.pates@nhs.…. Hauptthemen laut MEDLINE: Pneumonia, Pneumocystis, Opportunistic Infections. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Pneumocystis pneumonia (PCP) is an opportunistic infection that causes significant morbidity and mortality in the immunocompromised population. This population is growing and diversifying, yet contemporary epidemiology is lacking. We investigated the population-level incidence of PCP over the past decade. METHODS: We conducted a descriptive study of all hospital admissions in England from April 2012 to March 2022. PCP episodes, age, median length of stay, gender and episodes of other respiratory fungal infections were collected. Consumption of Trimethoprim-Sulfamethoxazole was obtained between January 2019 and May 2022. RESULTS: The incidence of PCP increased from 2·2-4·5/100,000 population between 2012/2013 and 2019/2020 (p < 0·0001). There was a drop in 2020/2021 to 2·7/100,000 before returning to 3.9/100,000 in 2021/2022. PCP episodes rose as a proportion of all-cause admissions as well as a proportion of episodes due to other fungal infections. The proportion of PCP patients aged 75+ increased from 14% to 26%. The median length of stay was 13.5 days. Consumption of intravenous Trimethoprim-Sulfamethoxazole increased from 0.24 × 100,000 to 0.30 × 100,000 defined daily doses. CONCLUSIONS: The incidence of PCP is rising rapidly and represents a significant burden to the healthcare system. Further study into who is at risk of PCP is needed to better determine who should be given prophylaxis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pneumonia, PneumocystisOpportunistic InfectionsHumansTrimethoprim, Sulfamethoxazole Drug CombinationIncidenceEnglandRetrospective Studies

Stichwörter der Autor:innen

EpidemiologyPneumocystis pneumonia

Substanzen

Trimethoprim, Sulfamethoxazole Drug Combination

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Kings College Hospital, Kings College Hospital NHS Foundation Trust, London, UK. Electronic address: k.pates@nhs.net.
  • Department of Respiratory Medicine, Kings College Hospital, Kings College Hospital NHS Foundation Trust, London, UK.
  • Centre for Rheumatic Diseases, King's College London, SE5 9RJ, UK.
  • Department of Haematology, Kings College Hospital, Kings College Hospital NHS Foundation Trust, London, UK.
  • Department of Microbiology, Kings College Hospital, Kings College Hospital NHS Foundation Trust, London, UK.

Zitieren

APA

Pates, K., Periselneris, J., Russell, M. D., Mehra, V., Schelenz, S., & Galloway, J. B. (2023). Rising incidence of Pneumocystis pneumonia: A population-level descriptive ecological study in England. Journal of Infection. https://doi.org/10.1016/j.jinf.2023.02.014

Vancouver

Pates K, Periselneris J, Russell MD, Mehra V, Schelenz S, Galloway JB. Rising incidence of Pneumocystis pneumonia: A population-level descriptive ecological study in England. Journal of Infection. 2023. doi:10.1016/j.jinf.2023.02.014

BibTeX
@article{Pates2023,
  author = {Pates, Katharine and Periselneris, Jimstan and Russell, Mark D and Mehra, Varun and Schelenz, Silke and Galloway, James B},
  title = {Rising incidence of Pneumocystis pneumonia: A population-level descriptive ecological study in England},
  journal = {Journal of Infection},
  year = {2023},
  doi = {10.1016/j.jinf.2023.02.014}
}
Kostenlos starten →